Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Ultrasound Method to Measure Fibrosis of the Liver in Children [NA]
Update on a pediatric ultrasound method to measure liver fibrosis; the trial was terminated and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIV [NA]
The UCLA-sponsored trial evaluating prevention strategies for Hepatitis B among homeless individuals at risk for HBV, Hepatitis C, and HIV h…
-
CLINICAL_TRIALS trial_result · 2017-01-26Clinical Trial Update: Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B [Phase 3]
A Phase 3 trial comparing telbivudine and entecavir in HBeAg-positive chronic hepatitis B completed, evaluating reduction of serum HBsAg lev…
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: A Prospective Study of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis B [Phase 2]
Phase 2 trial evaluating a combination of peginterferon alfa-2b and GM-CSF for chronic hepatitis B has completed.
-
CLINICAL_TRIALS research · 2017-01-25Clinical Trial Update: Establishment of Retrospective and Prospective Multicenter Cohort for Chronic Hepatitis B
A multicenter retrospective and prospective cohort study for chronic hepatitis B was established, combining historical and new patient data.…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: Clinical Efficacy of ABX203 Therapeutic Vaccine in HBeAg Negative Patients With Chronic Hepatitis B [Phase 2, Phase 3]
This clinical trial update reports the completion of a Phase 2/3 study evaluating the clinical efficacy of ABX203 Therapeutic Vaccine in HBe…
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: Study of Hepalatide(L47) at Phase Ib in Healthy Volunteers [Phase 1]
Phase Ib study of Hepalatide (L47) in healthy volunteers has completed. The update notes the completion of the trial investigating safety an…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Second Stage:Open-label Study of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B [Phase 2]
Phase 2 open-label study assessing a Mimogen-based therapeutic vaccine for chronic hepatitis B has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Phase 2 Trial of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B [Phase 2]
Phase 2 trial of a Mimogen-based therapeutic hepatitis B vaccine for chronic hepatitis B has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: A Study of the Safety and Efficacy of Pegylated Inferferon Alfa-2b (PEG-Intron™) Versus Pegylated Interferon Alfa-2a (PEGASYS™) in Participants With Chronic Hepatitis B (P08450) [Phase 3]
Phase 3 trial comparing PEG-Intron to PEGASYS in chronic hepatitis B was terminated with posted results in 2017.
-
CLINICAL_TRIALS research · 2017-01-12Clinical Trial Update: The Study of Two Different Chinese Traditional Medicine Treatment on Chronic Hepatitis B [NA]
This entry reports a clinical trial evaluating two different Chinese traditional medicine treatments for chronic hepatitis B, sponsored by X…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users [Phase 3]
Phase 3 clinical trial update evaluating a Hepatitis B vaccine model used for HIV vaccine trials in drug users; the study status is complete…
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma [Phase 4]
Phase 4 trial investigating prophylactic Baraclude (Entecavir) to prevent hepatitis B reactivation in patients who are HBsAg negative/HBcAb …
-
CLINICAL_TRIALS research · 2017-01-10Clinical Trial Update: Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy [Phase 4]
Phase 4 clinical trial investigates prophylactic entecavir to prevent hepatitis B reactivation in HBsAg-positive lymphoma patients treated w…
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: Performance of the HBV ELISPOT in the Detection of the T Cellular Immune Response in Patients Infected by HBV or Cured
Clinical trial update evaluating how the HBV ELISPOT assay performs in detecting T-cell immune responses in patients with hepatitis B infect…
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™ [Phase 4]
Phase 4 study assessing antibody persistence in children previously vaccinated with Infanrix Hexa or Infanrix-IPV/Hib; completed with result…
-
EMA guidance · 2016-12-16Direct-acting antivirals for hepatitis C: EMA confirms recommendation to screen for hepatitis B
EMA confirms recommendation to screen for hepatitis B when using direct-acting antivirals for hepatitis C.
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B Patients [Phase 4]
A Phase 4 comparative clinical trial evaluating antiviral activity and safety of an active drug in adults with chronic hepatitis B.
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Application of HBV Rapid Tests as a Tool for Wide-Use Screening [NA]
Completed a clinical trial assessing HBV rapid tests as a wide-use screening tool for Hepatitis B and related liver diseases. The study resu…
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests [NA]
A pilot study evaluated the use of simultaneous rapid tests for HIV, hepatitis B, and hepatitis C; the trial is completed and results were p…
-
FDA approval · 2016-12-07FDA Tentative Approval: TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Strides Pharma Science Limited)
FDA granted tentative approval for Strides Pharma Science Limited's generic Tenofovir Disoproxil Fumarate. The product is considered bioequi…
-
FDA approval · 2016-12-06FDA Approved: ENTECAVIR — Original Application (NorthStar RxLLC)
The FDA approved NorthStar RxLLC's original ANDA for entecavir, a generic antiviral for chronic hepatitis B.
-
EMA safety_alert · 2016-12-02PRAC warns of risk of hepatitis B re-activation with direct-acting antivirals for hepatitis C
The EMA’s Pharmacovigilance Risk Assessment Committee warns that hepatitis B re-activation can occur in patients with past or current hepati…
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants [Phase 4]
Phase 4 trial update on immunogenicity and safety of Infanrix Hexa in infants, with results posted after completion.
-
CLINICAL_TRIALS research · 2016-11-29Clinical Trial Update: REALM China Extension Study
A Chinese extension study for the REALM trial is underway for chronic hepatitis B, with the current status of the trial not disclosed.